SARS-CoV-2:

Carlota Arias-Hidalgo1, Pablo Juanes-Velasco1, Alba Iglesia-Sánchez1

  • 1Department of Medicine and General Cytometry Service-Nucleus, CIBERONC CB16/12/00400, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), IBSAL, Universidad de Salamanca-CSIC, Campus Miguel de Unamuno, s/n, Salamanca 37007, Spain.

PubMed
概括

与A型流感相比,COVID-19患者表现出不同的自身抗体概况,SARS-CoV-2引发了独特的免疫反应. 这些发现有助于理解病毒感染和开发向治疗.